U.S. Commerce removes Wuxi Biologics from unverified list

FILE PHOTO: Exterior photos of the North America headquarters of AstraZeneca

(Reuters) – The Biden administration said Thursday it had removed Wuxi Biologics, a company that makes ingredients for AstraZeneca’s COVID-19 vaccine, and about two dozen other Chinese entities from a so-called unverified list that forces U.S. suppliers to perform greater due diligence before shipping to them.

The Commerce Department also removed nine Russian entities from the unverified list and addded them to the entity list because the United States has been unable to conduct site visits. Companies are added to the unverified list if the United States cannot complete on-site visits to determine if they can be trusted to receive sensitive U.S. technology exports, inspections which in China require approval from the commerce ministry.

(Reporting by David Shepardson and Alex Alper; Editing by Doina Chiacu)

Related posts

Spirit Christmas expands New Jersey holiday pop-ups with new 2025 locations including Toms River

Flight attendant age discrimination suit moves forward in New Jersey court against United Airlines

Judge tosses inmate’s civil rights suit against Gov. Murphy over confinement claims